Minister Simon Harris announces €5m funding for researchers tackling major challenges under Irish Research Council’s Enterprise Partnership Scheme
October 2023
€5M IN FUNDING ANNOUNCED UNDER IRISH RESEARCH COUNCIL ENTERPRISE PARTNERSHIP SCHEME
On October 3rd, Minister Simon Harris announced funding of €5 million for researchers tackling major challenges under the latest round of the Irish Research Council’s Enterprise Partnership Scheme and Employment-Based Postgraduate Programme.
We are delighted that 4 of the 50 projects announced today are in partnership with Breakthrough Cancer Research:
Dr. Sofia Dominguez, a post-doctoral researcher in Dublin City University, working on Pancreatic cancer.
Shaun Hartigan a PhD student from University College Cork, working on Ovarian cancer.
Dr. Aidan O’Dowling, a surgeon working in UCD and St. Vincent’s University Hospital, researching Pancreatic cancer.
Ellen Treacy, a PhD student in Maynooth University, working on Ovarian cancer.
Announcing the awards, Minister for Further and Higher Education, Research, Innovation and Science, Simon Harris TD, said: ‘I am delighted to announce the latest projects to be selected for funding. These co-funded programmes train early-career researchers for the diversity of employment opportunities in industry, the public sector and the non-government sectors.
It’s exciting to see the broad experience and benefits that these partnerships will give to researchers and their enterprise-employer partners. These collaborative projects will allow researchers to gain valuable experience in the early stages of their careers, while employers and enterprises will benefit from having fresh perspectives, expertise, new ideas and knowledge.’
HAVE A BALL AND MAKE A DIFFERENCE!
We are on the countdown to our Winter Ball which takes place on Friday, 10th November 2023 at the five-star Fota Island Resort, Cork.
Treat yourself, your loved ones or friends to a wonderful evening. Broadcaster Jonathan Healy from Newstalk and TV3 will be MC for the night.
You'll enjoy an arrivals reception, a sumptuous four-course meal, amazing prizes, and special guest Risteárd Cooper. Then dance the night away with live music from Spring Break.
Tickets to this special fundraiser are €175 per person and can be bookedhereor call 021 422 6655.
We’re really proud to share this new 'Multiple Myeloma in Ireland' booklet.
Multiple Myeloma is a blood cancer that develops in the bone marrow.
Many people have heard of other blood cancers like leukaemia and lymphoma, but Multiple Myeloma is less well-known. Despite this, it is the second most-commonly diagnosed blood cancer, and lots of people in Ireland are living with this disease.
Multiple Myeloma is mostly diagnosed in people over 65, but about 20% of people are under the age of 60. Although many new treatments have been developed in recent years, it is not yet considered curable.
Developed by the Beaumont Royal College of Surgeons in Ireland Cancer Centre, a panel of people with Multiple Myeloma, patient advocates, researchers and clinicians, it aims to help people make informed decisions about their health and taking part in research.
Thethird episodeof the Irish Society of Gynaecological Oncology podcast series, hosted by Dr. Doireann O’Leary, and sponsored by Breakthrough Cancer Research is out now:Redefining Palliative Care.
In this episode, Dr. Katie Dennehy and Dr. Miriam Colleran, Consultants in Palliative Medicine speak about the care they give to patients and their families.
Anne speaks about her experience of living with Ovarian Cancer, and what Palliative Medicine means to her.
A beautiful quote from Dame Cicely Saunders, considered to be a palliative care pioneer, is referenced:
‘You matter because you are you, and you matter to the end of your life. We will do all we can, not only to help you die peacefully, but also to live until you die.’
You are receiving this email because you are a Breakthrough Cancer Research supporter or subscriber. We wish to keep you updated on the amazing research and cancer trials that your generous donations are funding. Please note that you can unsubscribe at any time. Thank you as always for your support.
